Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Commitment (own venture)

Rules 1.1.0 · as of 14 Sep 2026

Quote

Commitment (own venture)

“Phase 2 readout for VLS-01 (buccal film DMT) for TRD, anticipated in Q1 2026 Phase 2a readout for EMP-01 (oral R-MDMA) for social anxiety disorder, anticipated in Q1’2026”
· atai Life Sciences – Strong Phase 2b topline data for BPL-003 (5-MeO-DMT) and further strategic backing · own post

'Upcoming Milestones' list, last two items.

The forecaster's own organization can make the outcome happen by its own decision: clinic openings, product launches, hires, trial starts, filings by their own company. Listed in the commitments table, never scored.